Thomas Senderovitz

Thomas Senderovitz, MD is CEO of the Danish Association of the Pharmaceutical Industry, and a former SVP and Head of Data Science & AI at Novo Nordisk, where he led large-scale initiatives in analytics, digital transformation, and AI deployment within Development. His career spans executive leadership, public policy, and applied data science, providing a rare combination of technical depth and industry-level perspective.

Senderovitz is recognized for bridging innovation with regulatory and organizational realities, focusing on how emerging technologies translate into sustainable value. His work centers on responsible AI adoption, sector collaboration, and strengthening the competitiveness and societal impact of life science organizations.

‍